Skip to main content

$0.125 (0.00%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
16 May 2025 at 9:36pm
Register to track EMD and receive email alerts.

Emyria Receives Ethics Approval for MDMA-assisted Therapy

StockBot

416,823 posts

EMD released this announcement to the ASX on 8 June 2023, 9:10. The announcement is marked as price sensitive, and is 4 page(s) in length and 717.18kb in size.

You can view all announcements from EMD and see how they appear on a price chart on the announcements page.

At the date of this announcement, EMD was 0.004% short sold according to ASIC data. It was ranked the 574th most shorted stock on the ASX. It remains ranked 600th as of the latest reported data (17 April 2025).

Other Recent Announcements from EMD
Trading Halt 29 June 2023, 9:33
Emyria Receives Ethics Approval for MDMA-assisted Therapy 8 June 2023, 9:10
Section 708A(5)(e) Notice 10 May 2023, 18:37
Application for quotation of securities - EMD 10 May 2023, 18:26
Notification regarding unquoted securities - EMD 10 May 2023, 18:22
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track EMD and receive email alerts.